Lamotrigine Tablet
Product Images NDC 51672-4132

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 51672-4132). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lamotrigine 01)

Chemical structure of lamotrigine, showing a triazine ring bonded to a phenyl ring with two chlorine atoms and amino substituents.*

FDA Label Image

Figure 1 (Lamotrigine 02)

A line graph depicting failure probability (%) over time (weeks) comparing Lamotrigine and placebo groups. The graph shows two survival curves with Lamotrigine having a lower failure probability than placebo across the weeks, with censored data points marked on the curves.*

FDA Label Image

Figure 2 (Lamotrigine 03)

A Kaplan-Meier curve chart showing failure probability (%) over weeks for Lamotrigine versus Placebo. The y-axis represents failure probability from 0 to 100%, and the x-axis shows time in weeks from 0 to 80. The chart includes censored data points and demonstrates different survival curves for Lamotrigine and Placebo groups.*

FDA Label Image

25 mg Tablet (Lamotrigine 04)

Lamotrigine 25 mg oral tablet by Sun Pharmaceutical Industries, Inc. The white, round tablet is marked with 'LMT' on one side and '25' on the other, indicating the 25 mg strength.*

FDA Label Image

100 mg Tablet (Lamotrigine 05)

Lamotrigine 100 mg oral tablet by Sun Pharmaceutical Industries, Inc. The tablet is white, round, and scored, with imprint "LMT 100" on one side.*

FDA Label Image

150 mg Tablet (Lamotrigine 06)

Lamotrigine 150 mg round white oral tablet with imprint 'LMT 150'. The tablet is scored and uncoated. Labeler is Sun Pharmaceutical Industries, Inc.*

FDA Label Image

200 mg Tablet (Lamotrigine 07)

Lamotrigine 200 mg oral tablet imprinted with "LMT 200" on one side. The white, round tablet is manufactured by Sun Pharmaceutical Industries, Inc.*

FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Lamotrigine Tablets, USP 25 mg oral tablets. The label includes dosage strength, directions to dispense the accompanying Medication Guide, storage instructions, and manufacturer details listing Taro Pharmaceutical Industries Ltd. in Israel and Taro Pharmaceuticals U.S.A., Inc. in Hawthorne, NY. The NDC number and a barcode are also present.*

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Lamotrigine Tablets, USP 100 mg oral tablets packaging label. The label indicates a quantity of 100 tablets and includes caution text to verify the product dispensed. Manufactured by Taro Pharmaceutical Industries Ltd. and distributed by Taro Pharmaceuticals U.S.A., Inc. The label features storage instructions and a barcode.*

FDA Label Image

Principal Display Panel (150 mg Tablet Bottle Label)

Lamotrigine Tablets USP 150 mg oral tablets label showing a package of 60 tablets. Label includes instructions to dispense the accompanying medication guide, storage conditions at 20° to 25°C, and cautions to verify the product dispensed. The label lists the manufacturer as Taro Pharmaceutical Industries Ltd and distributor as Taro Pharmaceuticals U.S.A., Inc.*

FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

Lamotrigine Tablets USP 200 mg oral tablets packaging label showing 60 tablets per container. The label includes storage instructions and states the product is Rx only. Manufactured by Taro Pharmaceutical Industries Ltd. and distributed by Taro Pharmaceuticals U.S.A., Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.